Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 7Phase 3 4Phase 1/2 4Phase 1 2

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

OTHER 2NETWORK 2

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4Thoracic 1Breast 1

Conditions

Brain Neoplasms 3Small Cell Lung Carcinoma 1Neoplasm Metastasis 1Lung Neoplasms 1Glioblastoma 1Cognition Disorders 1Central Nervous System Carcinoma 1

Interventions

Radiotherapy 64Temozolomide 59Vincristine 33Cyclophosphamide 32Carboplatin 30Radiosurgery 26Etoposide 25Cisplatin 25Lomustine 24Magnetic Resonance Spectroscopy 19Filgrastim 17Doxorubicin 15Bevacizumab 15Radiation 13Specimen Handling 12Granulocyte Colony-Stimulating Factor 12Surgical Procedures, Operative 11Isotretinoin 11Melphalan 10Carmustine 10Procarbazine 9Platinum 9Peripheral Blood Stem Cell Transplantation 9Chemotherapy, Adjuvant 9etoposide phosphate 7Topotecan 71,2-diaminocyclohexaneplatinum II citrate 7sargramostim 6Thiotepa 6Radiotherapy, Intensity-Modulated 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Mental Status and Dementia Tests × CNS × Clear all
NCT04804644 2026-05-04

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

NRG Oncology

Phase 3 Recruiting
200 enrolled
CNSThoracic

Brain Neoplasms, Lung Neoplasms, Small Cell Lung Carcinoma

NCT01592968 2026-03-09

Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Treating Patients With Newly Diagnosed Non-melanoma Brain Metastases

M.D. Anderson Cancer Center

Phase 3 Active not recruiting
88 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis

NCT04939597 2025-12-22

A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor

Children's Oncology Group

Phase 3 Active not recruiting
192 enrolled
CNS

Central Nervous System Carcinoma

NCT01290939 2021-02-15

Bevacizumab and Lomustine for Recurrent GBM

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
592 enrolled
CNS

Brain Neoplasms, Cognition Disorders, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡